GETI.B

209.1

+1.7%↑

CAMX

609

+2.78%↑

BIOAB

320.6

+1.84%↑

EKTA.B

55.85

+3.04%↑

AMBEA

134.4

-0.44%↓

GETI.B

209.1

+1.7%↑

CAMX

609

+2.78%↑

BIOAB

320.6

+1.84%↑

EKTA.B

55.85

+3.04%↑

AMBEA

134.4

-0.44%↓

GETI.B

209.1

+1.7%↑

CAMX

609

+2.78%↑

BIOAB

320.6

+1.84%↑

EKTA.B

55.85

+3.04%↑

AMBEA

134.4

-0.44%↓

GETI.B

209.1

+1.7%↑

CAMX

609

+2.78%↑

BIOAB

320.6

+1.84%↑

EKTA.B

55.85

+3.04%↑

AMBEA

134.4

-0.44%↓

GETI.B

209.1

+1.7%↑

CAMX

609

+2.78%↑

BIOAB

320.6

+1.84%↑

EKTA.B

55.85

+3.04%↑

AMBEA

134.4

-0.44%↓

Home・Akcijų sąrašas・Vitrolife AB

V
Vitrolife AB

Uždarymo kaina

138.6 0.36

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

134.7

Max

139.2

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-30M 102M
Pardavimai	-36M 835M
P/E Sektoriaus vid.	42.154 77.671
Pelnas, tenkantis vienai akcijai	0.753
Dividendų pajamingumas	0.78
Pelno marža	12.216
Darbuotojai	1,100
EBITDA	118M 255M

Dividendai
By Dow Jones
Dividendų pajamingumas Sektoriaus vid.	0.78% 2.35%
Kitas uždarbis	2026-02-03

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-1.3B 19B
Ankstesnė atidarymo kaina	138.24
Ankstesnė uždarymo kaina	138.6

Vitrolife AB Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-11 23:03; UTC

Įsigijimai, susijungimai, perėmimai

FTC Sues to Block Henkel's $725 Million Acquisition of Liquid Nails From PE Firm

2025-12-11 22:06; UTC

Įsigijimai, susijungimai, perėmimai

Scentre to Sell $456 Million Westfield Chermside Mall Stake to Dexus-Managed Fund

2025-12-11 21:50; UTC

Uždarbis

Costco Same-Store Sales, Membership Fees Rose in 1Q

2025-12-11 23:45; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-12-11 23:44; UTC

Rinkos pokalbiai

Nikkei May Rise After U.S. Stock Indexes Hit Record Highs -- Market Talk

2025-12-11 23:43; UTC

Įsigijimai, susijungimai, perėmimai

Destination XL to Merge With Oaktree-Backed Fullbeauty Brands -- Update

2025-12-11 23:41; UTC

Uždarbis

Costco Logs Higher Sales, Eyes Expansion to Fuel Membership Growth -- Update

2025-12-11 23:37; UTC

Rinkos pokalbiai

Gold Steady, Underpinned by Dollar's Weakness -- Market Talk

2025-12-11 23:31; UTC

Uždarbis

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

2025-12-11 22:48; UTC

Įsigijimai, susijungimai, perėmimai

FTC Sues to Block Henkel's $725M Acquisition of Liquid Nails From PE Firm

2025-12-11 22:35; UTC

Uždarbis

Costco Sold 4.5 Million Pies Ahead of Thanksgiving. Despite Earnings Beat, the Stock Fails to Gain Traction. -- Barrons.com

2025-12-11 22:30; UTC

Uždarbis

Broadcom Beats Earnings. The Stock Wavers After Customer Updates. -- Barrons.com

2025-12-11 22:09; UTC

Įsigijimai, susijungimai, perėmimai

FTC Alleges Henkel Deal Would Combine Two Biggest Brands of Construction Adhesives Sold at Stores Like Home Depot, Leading to Higher Prices

2025-12-11 22:06; UTC

Įsigijimai, susijungimai, perėmimai

FTC Sues to Block Henkel From Buying Loctite Competitor Liquid Nails

2025-12-11 22:05; UTC

Uždarbis

Broadcom Beats Revenue and Profit Forecasts as AI Chip Sales Climb -- Update

2025-12-11 21:51; UTC

Įsigijimai, susijungimai, perėmimai

Scentre to Sell $456M Westfield Chermside Mall Stake to Dexus-Managed Fund

2025-12-11 21:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-12-11 21:39; UTC

Uždarbis

Broadcom Beats Earnings. The Stock Rises. -- Barrons.com

2025-12-11 21:39; UTC

Uždarbis

Broadcom Reports $18 Billion in Revenue as AI Chip Sales Climb -- WSJ

2025-12-11 21:38; UTC

Uždarbis

Costco Tops Earnings Estimates but Stock Fails to Gain Traction -- Barrons.com

2025-12-11 21:37; UTC

Uždarbis

These Stocks Moved the Most Today: Oracle, Nvidia, Broadcom, Planet Labs, Visa, Ciena, Gemini Space Station, and More -- Barrons.com

2025-12-11 21:37; UTC

Rinkos pokalbiai

Broadcom Sees AI Revenue Doubling -- Market Talk

2025-12-11 21:34; UTC

Įsigijimai, susijungimai, perėmimai

Scentre Will Temporarily Invest A$50M in the New Dexus Fund

2025-12-11 21:29; UTC

Įsigijimai, susijungimai, perėmimai

Dexus Aiming for Long-Term Holding of A$50M in Fund

2025-12-11 21:28; UTC

Rinkos pokalbiai

BLS Publishing Calendar Delays Now Pushing Economic Data Into February -- Market Talk

2025-12-11 21:28; UTC

Įsigijimai, susijungimai, perėmimai

Dexus Expects to Introduce Additional Third-Party Equity in FY26

2025-12-11 21:28; UTC

Įsigijimai, susijungimai, perėmimai

Dexus: Third Party Investors to Contribute Remainder

2025-12-11 21:27; UTC

Įsigijimai, susijungimai, perėmimai

Dexus to Put Initial A$170M into New Dexus Strategic Investment Trust

2025-12-11 21:26; UTC

Įsigijimai, susijungimai, perėmimai

Scentre: Dexus Wholesale Shopping Centre Fund Already Holds 25% Stake

2025-12-11 21:25; UTC

Įsigijimai, susijungimai, perėmimai

Scentre: Purchase Price Represents Book Value, 5% Value Cap Rate

Akcijų palyginimas

Kainos pokytis

Vitrolife AB Prognozė

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.